The sensitivity gene GPR56 in NCRT for ESCC showed a significant decrease in expression, and in combination with MPR analysis, it may have more significant predictive value for therapeutic efficacy, serving as a potential molecular marker for predicting the effectiveness of NCRT for ESCC. The gene discussed is ADGRG1; the disease is esophageal squamous cell carcinoma.